Venous thromboembolism - apixaban (hip and knee surgery) (TA245)
Fast, easy summary view of NICE guidance on 'venous thromboembolism'
NICE recommends apixaban as a possible treatment to reduce the risk of venous thromboembolism in adults.
Who can have apixaban?
You should be able to have apixaban if you have had surgery to replace your hip or knee.
Why has NICE said this?
NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended apixaban because it works better and costs less than one of the most commonly used drugs available on the NHS that is used to reduce the risk of thromboembolism.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: venous thromboembolism
- None found
This page was last updated: 27 June 2012
- Web format
- Full Guidance (PDF)
- TA245 Apixaban i leihau'r risg o thrombo-emboledd gwythiennol ar ôl llawdriniaeth i osod clun neu ben-glin newydd: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
See this guidance in practice
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.